Published in Cell Biochem Biophys on November 01, 2013
STAT3 signaling in pulmonary arterial hypertension. JAKSTAT (2012) 1.04
PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21. PLoS One (2015) 0.81
Pulmonary hypertension secondary to left-heart failure involves peroxynitrite-induced downregulation of PTEN in the lung. Hypertension (2013) 0.80
Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension. J Am Heart Assoc (2013) 0.80
HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy. Mol Cell Biochem (2017) 0.77
Regulation and function of miR-214 in pulmonary arterial hypertension. Pulm Circ (2016) 0.76
Exogenous spermine inhibits the proliferation of human pulmonary artery smooth muscle cells caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways. Int J Mol Med (2015) 0.75
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 21.42
Inflammation and atherosclerosis. Circulation (2002) 20.77
Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A (2001) 6.25
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol (2004) 2.90
Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol (1997) 2.52
PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem (1999) 2.07
New insights into PTEN. J Cell Sci (2007) 2.04
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol (2009) 1.88
PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet (2001) 1.87
Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol (1998) 1.85
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat Rev Drug Discov (2007) 1.83
Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation (2008) 1.82
Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol (2002) 1.79
Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res (2009) 1.78
A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med (2003) 1.74
Phosphorylation of HDM2 by Akt. Oncogene (2002) 1.63
PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem (2002) 1.63
EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem (2007) 1.59
Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest (2000) 1.39
Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res (2002) 1.31
Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res (2008) 1.25
p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol (2011) 1.24
Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res (2011) 1.17
Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol (2009) 1.16
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet (2006) 1.13
Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Appl Physiol (1985) (2007) 1.07
Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia. Arterioscler Thromb Vasc Biol (2004) 1.07
Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest (1998) 1.00
A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. Am J Pathol (2009) 0.98
PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol (2011) 0.96
Current therapeutics and practical management strategies for pulmonary arterial hypertension. Am Heart J (2011) 0.96
Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. J Pharmacol Exp Ther (2009) 0.94
Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function. Vasc Health Risk Manag (2010) 0.93
Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (i/r) injury: useful techniques for cardiovascular drug discovery. Curr Drug Discov Technol (2008) 0.90
PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys (2004) 0.86
Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol (2007) 0.86
Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways. Respir Res (2009) 0.86
Advancing therapy for pulmonary arterial hypertension: can animal models help? Am J Respir Crit Care Med (2004) 0.82
The rat is a poor animal model for the study of human pulmonary hypertension. Cardioscience (1992) 0.81
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis. Cardiovasc Hematol Disord Drug Targets (2008) 0.81
Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest (2005) 0.81
Forever young?: nerve growth factor, sympathetic fibers, and right ventricle pressure overload. Circ Res (2007) 0.77
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science (2004) 4.81
Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature (2009) 4.21
Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol (2009) 2.39
Novel particulate spin probe for targeted determination of oxygen in cells and tissues. Free Radic Biol Med (2003) 2.18
Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci U S A (2010) 2.11
A Proactive Approach to Neonates Born at 23 Weeks of Gestation. Obstet Gynecol (2015) 2.02
Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol (2007) 1.96
Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity (2012) 1.75
Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. Am J Physiol Heart Circ Physiol (2009) 1.74
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol (2010) 1.70
Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med (2002) 1.69
CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol (2004) 1.66
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
Absolute oxygen tension (pO(2)) in murine fatty and muscle tissue as determined by EPR. Magn Reson Med (2005) 1.63
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res (2011) 1.61
EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem (2007) 1.59
Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res (2009) 1.57
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood (2006) 1.56
The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A (2009) 1.51
Endothelium-derived nitric oxide regulates postischemic myocardial oxygenation and oxygen consumption by modulation of mitochondrial electron transport. Circulation (2005) 1.51
Mouse development with a single E2F activator. Nature (2008) 1.51
Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res (2008) 1.50
Theory, instrumentation, and applications of electron paramagnetic resonance oximetry. Chem Rev (2010) 1.48
Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid Redox Signal (2007) 1.47
Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol (2010) 1.47
Fast EPR imaging at 300 MHz using spinning magnetic field gradients. J Magn Reson (2004) 1.45
In vivo imaging of changes in tumor oxygenation during growth and after treatment. Magn Reson Med (2007) 1.42
Methods for noninvasive imaging of tissue hypoxia. Antioxid Redox Signal (2007) 1.39
Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther (2007) 1.38
Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. Eur J Immunol (2004) 1.38
Germinal center B cells govern their own fate via antibody feedback. J Exp Med (2013) 1.36
Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol (2003) 1.36
Simultaneous measurement of oxygenation in intracellular and extracellular compartments of lung microvascular endothelial cells. Antioxid Redox Signal (2004) 1.33
Application of a trityl-based radical probe for measuring superoxide. Free Radic Biol Med (2003) 1.29
A parametric approach to spectral-spatial EPR imaging. J Magn Reson (2007) 1.26
Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 1.25
Progressive EPR imaging with adaptive projection acquisition. J Magn Reson (2005) 1.22
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium. Blood (2008) 1.21
Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther (2009) 1.21
Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction. Mol Cell Biol (2012) 1.21
Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proc Natl Acad Sci U S A (2006) 1.20
Oxidative stress in cardiovascular disease. Indian J Biochem Biophys (2009) 1.20
In vivo EPR measurement of glutathione in tumor-bearing mice using improved disulfide biradical probe. Free Radic Biol Med (2008) 1.19
Role of oxygen in postischemic myocardial injury. Antioxid Redox Signal (2007) 1.19
Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line. BMC Cancer (2006) 1.19
Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol (2006) 1.19
A naphthalocyanine-based EPR probe for localized measurements of tissue oxygenation. Free Radic Biol Med (2002) 1.18
Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol (2013) 1.18
Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am J Physiol Heart Circ Physiol (2007) 1.17
Mapping of the B1 field distribution of a surface coil resonator using EPR imaging. Magn Reson Med (2002) 1.17
In vivo proton electron double resonance imaging of the distribution and clearance of nitroxide radicals in mice. Magn Reson Med (2006) 1.17
EPR/NMR co-imaging for anatomic registration of free-radical images. Magn Reson Med (2002) 1.16
Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. J Immunol (2002) 1.16
Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res (2005) 1.16
HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. Mol Cancer Res (2010) 1.16
EPR oximetry in three spatial dimensions using sparse spin distribution. J Magn Reson (2008) 1.15
Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget (2011) 1.15
Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass. J Heart Lung Transplant (2008) 1.14
Reactivity of molecular oxygen with ethoxycarbonyl derivatives of tetrathiatriarylmethyl radicals. J Org Chem (2006) 1.14
Measurement of oxygen consumption in mouse aortic endothelial cells using a microparticulate oximetry probe. Arch Biochem Biophys (2003) 1.14
Fast 3D spatial EPR imaging using spiral magnetic field gradient. J Magn Reson (2007) 1.14
Reaction of superoxide with trityl radical: implications for the determination of superoxide by spectrophotometry. Arch Biochem Biophys (2004) 1.12
Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One (2009) 1.11
Deconvolution algorithm based on automatic cutoff frequency selection for EPR imaging. Magn Reson Med (2003) 1.11
Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol (2004) 1.11
Proton electron double resonance imaging of the in vivo distribution and clearance of a triaryl methyl radical in mice. Magn Reson Med (2002) 1.11
Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol (2007) 1.08
Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A (2010) 1.08
Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic Biol Med (2007) 1.07
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer (2009) 1.07
Application of magnetic field over-modulation for improved EPR linewidth measurements using probes with Lorentzian lineshape. J Magn Reson (2006) 1.07
Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation. Antioxid Redox Signal (2009) 1.06
In vivo measurement and imaging of tumor oxygenation using coembedded paramagnetic particulates. Magn Reson Med (2004) 1.06
Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res (2009) 1.05
Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol (2009) 1.05
Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol (2005) 1.04
Intestinal ischemia complicating ascending aortic dissection: first things first. Ann Thorac Surg (2007) 1.04
Placental transfusion strategies in very preterm neonates: a systematic review and meta-analysis. Obstet Gynecol (2014) 1.04
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice. J Exp Med (2011) 1.03
Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses. Semin Immunol (2008) 1.03
Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition. Cancer (2008) 1.03
C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol (2005) 1.03
Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother Pharmacol (2006) 1.03